Medtronic Unveils SURGICAL SYNERGY™ Smart Orthopedic Surgery Integrated Solution at CIIE to Advance Intelligent and High-Quality Orthopedic Development in China
Nov 07, 2021 21:52
CST Updated
21:52
Medtronic
Chronic Disease Medical Device and Therapy Developer
November 7, 2021, Shanghai — Medtronic, a global leader in spine and neurosurgery, showcases SURGICAL SYNERGY™The integrated smart orthopedic surgical solution made a high-profile debut at the 4th China International Import Expo (hereinafter referred to as "CIIE"). Leveraging the CIIE, the commercialization of this solution in China will be accelerated to drive the establishment of new industry standards for smart orthopedics, build an innovative ecosystem for smart orthopedics, and thereby advance disciplinary development and high-quality development in the field of orthopedics.
SURGICAL SYNERGY™ Medtronic Intelligent Orthopedic Integrated Solution Launch Ceremony
Bringing Cutting-Edge Concepts to China, Empowering Orthopedic Clinical Capacity Building
Currently, driven by the dual forces of population aging and the upgrading of healthcare consumption, the fundamentals of China’s medical market remain robust. According to 《China Health and Family Planning Statistical Yearbook》, the annual number of newly diagnosed patients with orthopedic conditions in China is expected to exceed 2 million. Coupled with the accelerated aging process, China is poised to become the world’s largest orthopedic market within a decade. Statistical data on the development of China’s health services in 2020 indicates that the number of licensed physicians per 1,000 population stands at only 2.9, with orthopedic specialists being even scarcer. Clinical demand continues to grow; however, China’s orthopedic medical resources and clinical capabilities remain relatively inadequate and unevenly distributed, particularly in spine surgery, which entails higher technical complexity.
At this CIIE, the SURGICAL SYNERGY™ Intelligent Integrated Orthopedic Surgical Solution, officially released by Medtronic, offers an innovative approach to addressing the challenges in the development of orthopedics in China. SURGICAL SYNERGY™ is based on the newly launched Medtronic MAZOR™X Spine Intelligent Navigation Robot and the industry-leading StealthStation™An intelligent integrated orthopedic solution for surgical navigation systems, centered on spinal therapies and surgical procedures. Through standardized workflows, it synergizes and integrates the implants, instruments, smart devices, and various energy and power systems utilized in spinal surgeries. SURGICAL SYNERGY™ provides clinicians with robust intelligent preoperative planning capabilities and precise, navigation-guided surgical execution featuring continuous intraoperative visualization and predictable outcomes, thereby making spinal surgery more precise, safe, efficient, and intelligent, and achieving powerful synergistic integration and spillover effects.
At the same time, due to the rich vascularity and dense innervation surrounding the spine, spinal surgery has long been described as "a dance on the edge of a cliff," placing exceptionally high demands on the surgeon's professional competence and surgical experience. SURGICAL SYNERGY™The integrated intelligent orthopedic surgical solution provides standardized perioperative workflows and surgical operational support encompassing preoperative planning, intraoperative procedures, and postoperative recovery. It significantly shortens the learning curve for clinicians, improves patient outcomes, and truly brings greater peace of mind to patients and greater confidence to physicians. Medtronic is committed to establishing SURGICAL SYNERGY™ as a new standard for intelligent orthopedic surgery, aiming to achieve the goal of "simplifying complex surgeries and standardizing simple ones." This initiative will promote the widespread adoption and extension of advanced surgical techniques to lower-tier healthcare facilities, thereby facilitating the implementation of a tiered healthcare system.
Ms. Jing Yu, Vice President of Medtronic and General Manager, Orthopedics and Neurosurgery Business, China
“As an innovative leader in the orthopedics industry, Medtronic not only boasts a comprehensive product portfolio covering implants, instruments, and robotics, but also possesses robust local capabilities spanning from R&D and planning to manufacturing and distribution, as well as from professional education to academic support. This ensures that while introducing advanced medical solutions, we can achieve rapid and efficient localization and implementation,” said Yu Jing, Vice President of Medtronic and General Manager of the Orthopedics & Neurosurgery Business at Medtronic China. “As one of the first multinational medical enterprises to participate in the CIIE, we have fully benefited from its spillover effects. We look forward to the SURGICAL SYNERGY™ Intelligent Orthopedic Integrated Solution, driven by the powerful synergy and spillover effects of the CIIE, to fully empower hospital development, drive clinical innovation, and benefit patients across China.”
Innovative Bone Repair Therapy Debuts at CIIE, Completing a Crucial Link in Ensuring Postoperative Efficacy
INFUSE™Bone repair material (*This product has not yet been marketed in China.)
At the press conference, INFUSE™Bone Repair Materials: The Upcoming Addition to SURGICAL SYNERGY™The new product featuring an integrated intelligent orthopedic surgery solution was publicly unveiled for the first time.
According to Zhou Zhongjie, Associate Chief Physician in the Department of Orthopedics at West China Hospital, Sichuan University, spinal nonunion currently accounts for 45%–56% of the cases requiring revision surgery following spinal fixation and fusion in China.
Professor Li Weishi, Department of Orthopaedics, Peking University Third Hospital
Professor Li Weishi from the Department of Orthopedics at Peking University Third Hospital noted, "Innovative bone repair therapies and technologies will help improve the current status of orthopedic diagnosis and treatment in China and enhance patients' postoperative quality of life."
INFUSE™Leveraging its unique osteoinductive mechanism, the bone repair material participates throughout the entire bone healing process, significantly accelerating the rate of bone fusion and enhancing the quality of bone formation. Since its introduction, INFUSE has benefited over 2 million patients across more than 50 countries worldwide.™Bone Repair Therapy. As a cutting-edge technology that promotes bone healing at the molecular and cellular levels, its accelerated introduction will consolidate SURGICAL SYNERGY.™A key component in the postoperative healing phase of the intelligent integrated orthopedic solution.
Prof. Song Yueming, Department of Orthopedics, West China Hospital of Sichuan University
INFUSE™The plaque-awarding ceremony for the International Multicenter Clinical Research Center and the Medtronic Bone Repair Technical Specification Training and Education Center was also held concurrently. Professor Song Yueming from the Department of Orthopedics, West China Hospital, Sichuan University, expressed his expectations and best wishes for the center. Leveraging this research center, Medtronic will collaborate with industry experts to conduct INFUSE in parallel with global developments.™International collaboration and clinical research, and promote and popularize standardized applications.
Building an Open Innovation Ecosystem: Multi-Party Collaboration to Drive High-Quality Development of China's Orthopedic Industry
Guided by the mission to "alleviate pain, restore health, and extend life," Medtronic remains steadfastly committed to benefiting patients across China through advanced medical technologies. While continuously introducing industry-leading innovative technologies, Medtronic China’s Orthopedics and Neurosurgery business has maintained a long-term commitment to investing in clinical education and academic exchange, promoting the widespread adoption of advanced therapies and enhancing clinical capabilities. This supports the development of a National Orthopedic Medical Center equipped with comprehensive diagnostic, therapeutic, and clinical service capabilities for orthopedic diseases, thereby ultimately benefiting a broader patient population.
WithHealthcare ReformAs the trend continues to deepen, the timing for localization within China's healthcare industry is gradually maturing. Medtronic China’s Orthopedics and Neurosurgery business also plans to leverage the SURGICAL SYNERGY™ integrated smart orthopedics solution to build an open, continuously evolving innovation platform rooted in China's healthcare environment. Through extensive collaboration with clinical and research institutions and synergy with ecosystem partners, it aims to advance the localization of orthopedic innovation in China, enhance domestic orthopedic innovation capabilities, and empower China's medical innovation sector to go global.（Bioon bioon）
SURGICAL SYNERGY™ Medtronic Intelligent Orthopedic Integrated Solution Launch Ceremony
Bringing Cutting-Edge Concepts to China, Empowering Orthopedic Clinical Capacity Building
Currently, driven by the dual forces of population aging and the upgrading of healthcare consumption, the fundamentals of China’s medical market remain robust. According to 《China Health and Family Planning Statistical Yearbook》, the annual number of newly diagnosed patients with orthopedic conditions in China is expected to exceed 2 million. Coupled with the accelerated aging process, China is poised to become the world’s largest orthopedic market within a decade. Statistical data on the development of China’s health services in 2020 indicates that the number of licensed physicians per 1,000 population stands at only 2.9, with orthopedic specialists being even scarcer. Clinical demand continues to grow; however, China’s orthopedic medical resources and clinical capabilities remain relatively inadequate and unevenly distributed, particularly in spine surgery, which entails higher technical complexity.
At this CIIE, the SURGICAL SYNERGY™ Intelligent Integrated Orthopedic Surgical Solution, officially released by Medtronic, offers an innovative approach to addressing the challenges in the development of orthopedics in China. SURGICAL SYNERGY™ is based on the newly launched Medtronic MAZOR™X Spine Intelligent Navigation Robot and the industry-leading StealthStation™An intelligent integrated orthopedic solution for surgical navigation systems, centered on spinal therapies and surgical procedures. Through standardized workflows, it synergizes and integrates the implants, instruments, smart devices, and various energy and power systems utilized in spinal surgeries. SURGICAL SYNERGY™ provides clinicians with robust intelligent preoperative planning capabilities and precise, navigation-guided surgical execution featuring continuous intraoperative visualization and predictable outcomes, thereby making spinal surgery more precise, safe, efficient, and intelligent, and achieving powerful synergistic integration and spillover effects.
At the same time, due to the rich vascularity and dense innervation surrounding the spine, spinal surgery has long been described as "a dance on the edge of a cliff," placing exceptionally high demands on the surgeon's professional competence and surgical experience. SURGICAL SYNERGY™The integrated intelligent orthopedic surgical solution provides standardized perioperative workflows and surgical operational support encompassing preoperative planning, intraoperative procedures, and postoperative recovery. It significantly shortens the learning curve for clinicians, improves patient outcomes, and truly brings greater peace of mind to patients and greater confidence to physicians. Medtronic is committed to establishing SURGICAL SYNERGY™ as a new standard for intelligent orthopedic surgery, aiming to achieve the goal of "simplifying complex surgeries and standardizing simple ones." This initiative will promote the widespread adoption and extension of advanced surgical techniques to lower-tier healthcare facilities, thereby facilitating the implementation of a tiered healthcare system.
Ms. Jing Yu, Vice President of Medtronic and General Manager, Orthopedics and Neurosurgery Business, China
“As an innovative leader in the orthopedics industry, Medtronic not only boasts a comprehensive product portfolio covering implants, instruments, and robotics, but also possesses robust local capabilities spanning from R&D and planning to manufacturing and distribution, as well as from professional education to academic support. This ensures that while introducing advanced medical solutions, we can achieve rapid and efficient localization and implementation,” said Yu Jing, Vice President of Medtronic and General Manager of the Orthopedics & Neurosurgery Business at Medtronic China. “As one of the first multinational medical enterprises to participate in the CIIE, we have fully benefited from its spillover effects. We look forward to the SURGICAL SYNERGY™ Intelligent Orthopedic Integrated Solution, driven by the powerful synergy and spillover effects of the CIIE, to fully empower hospital development, drive clinical innovation, and benefit patients across China.”
Innovative Bone Repair Therapy Debuts at CIIE, Completing a Crucial Link in Ensuring Postoperative Efficacy
INFUSE™Bone repair material (*This product has not yet been marketed in China.)
At the press conference, INFUSE™Bone Repair Materials: The Upcoming Addition to SURGICAL SYNERGY™The new product featuring an integrated intelligent orthopedic surgery solution was publicly unveiled for the first time.
According to Zhou Zhongjie, Associate Chief Physician in the Department of Orthopedics at West China Hospital, Sichuan University, spinal nonunion currently accounts for 45%–56% of the cases requiring revision surgery following spinal fixation and fusion in China.
Professor Li Weishi, Department of Orthopaedics, Peking University Third Hospital
Professor Li Weishi from the Department of Orthopedics at Peking University Third Hospital noted, "Innovative bone repair therapies and technologies will help improve the current status of orthopedic diagnosis and treatment in China and enhance patients' postoperative quality of life."
INFUSE™Leveraging its unique osteoinductive mechanism, the bone repair material participates throughout the entire bone healing process, significantly accelerating the rate of bone fusion and enhancing the quality of bone formation. Since its introduction, INFUSE has benefited over 2 million patients across more than 50 countries worldwide.™Bone Repair Therapy. As a cutting-edge technology that promotes bone healing at the molecular and cellular levels, its accelerated introduction will consolidate SURGICAL SYNERGY.™A key component in the postoperative healing phase of the intelligent integrated orthopedic solution.
Prof. Song Yueming, Department of Orthopedics, West China Hospital of Sichuan University
INFUSE™The plaque-awarding ceremony for the International Multicenter Clinical Research Center and the Medtronic Bone Repair Technical Specification Training and Education Center was also held concurrently. Professor Song Yueming from the Department of Orthopedics, West China Hospital, Sichuan University, expressed his expectations and best wishes for the center. Leveraging this research center, Medtronic will collaborate with industry experts to conduct INFUSE in parallel with global developments.™International collaboration and clinical research, and promote and popularize standardized applications.
Building an Open Innovation Ecosystem: Multi-Party Collaboration to Drive High-Quality Development of China's Orthopedic Industry
Guided by the mission to "alleviate pain, restore health, and extend life," Medtronic remains steadfastly committed to benefiting patients across China through advanced medical technologies. While continuously introducing industry-leading innovative technologies, Medtronic China’s Orthopedics and Neurosurgery business has maintained a long-term commitment to investing in clinical education and academic exchange, promoting the widespread adoption of advanced therapies and enhancing clinical capabilities. This supports the development of a National Orthopedic Medical Center equipped with comprehensive diagnostic, therapeutic, and clinical service capabilities for orthopedic diseases, thereby ultimately benefiting a broader patient population.
WithHealthcare ReformAs the trend continues to deepen, the timing for localization within China's healthcare industry is gradually maturing. Medtronic China’s Orthopedics and Neurosurgery business also plans to leverage the SURGICAL SYNERGY™ integrated smart orthopedics solution to build an open, continuously evolving innovation platform rooted in China's healthcare environment. Through extensive collaboration with clinical and research institutions and synergy with ecosystem partners, it aims to advance the localization of orthopedic innovation in China, enhance domestic orthopedic innovation capabilities, and empower China's medical innovation sector to go global.（Bioon bioon）
“As an innovation leader in the orthopedics industry, Medtronic not only boasts a comprehensive product portfolio spanning implants, devices, and robotics, but also possesses end-to-end local capabilities—from R&D and planning to manufacturing and distribution, and from professional education to academic support. This ensures that while introducing advanced medical solutions, we can achieve rapid and efficient localization and implementation,” said Yu Jing, Vice President and General Manager of Medtronic China’s Orthopedics and Neurosurgery business. “As one of the first multinational healthcare companies to participate in the CIIE, we have fully benefited from its spillover effects. We look forward to the SURGICAL SYNERGY™ intelligent integrated orthopedics solution also leveraging the expo’s powerful synergy and spillover effects to fully empower hospital development, drive clinical innovation, and benefit patients across China.”
Innovative Bone Repair Therapy Debuts at CIIE, Filling a Crucial Gap in Ensuring Postoperative Efficacy
INFUSE™Bone Repair Material (*This product has not yet been marketed in China)